Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression

被引：9

作者：

Ciancio, G

Miller, A

Burke, GW

Gharagozloo, H

Rosen, A

Roth, D

Kupin, W

Pinna, A

Cespedes, M

Esquenazi, V

Miller, J

机构：

[1] Univ Miami, Sch Med, Dept Surg, Div Transplantat, Miami, FL 33101 USA

[2] Univ Miami, Sch Med, Dept Med, Miami, FL 33101 USA

[3] Miami Vet Affairs Med Ctr, Miami, FL USA

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(00)02309-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1013 / 1014

页数：2

共 13 条

[1] EARLY VERSUS LATE ACUTE RENAL-ALLOGRAFT REJECTION - IMPACT ON CHRONIC REJECTION [J].

BASADONNA, GP ;

MATAS, AJ ;

GILLINGHAM, KJ ;

PAYNE, WD ;

DUNN, DL ;

SUTHERLAND, DER ;

GORES, PF ;

GRUESSNER, RWG ;

NAJARIAN, JS .

TRANSPLANTATION, 1993, 55 (05) :993-995

[2]

BOYCE NW, 1988, TRANSPLANTATION, V45, P706

[3] CAUSES OF GRAFT LOSS BEYOND 2 YEARS IN THE CYCLOSPORINE ERA [J].

DUNN, J ;

GOLDEN, D ;

VANBUREN, CT ;

LEWIS, RM ;

LAWEN, J ;

KAHAN, BD .

TRANSPLANTATION, 1990, 49 (02) :349-353

[4] THE INCIDENCE AND IMPACT OF EARLY REJECTION EPISODES ON GRAFT OUTCOME IN RECIPIENTS OF 1ST CADAVER KIDNEY-TRANSPLANTS [J].

GULANIKAR, AC ;

MACDONALD, AS ;

SUNGURTEKIN, U ;

BELITSKY, P .

TRANSPLANTATION, 1992, 53 (02) :323-328

[5] EFFECT OF TREATMENT WITH CYCLOSPORINE VERSUS AZATHIOPRINE ON INCIDENCE AND SEVERITY OF CYTOMEGALO-VIRUS INFECTION POSTTRANSPLANTATION [J].

JOHNSON, M ;

ANDIMAN, W ;

GAUDIO, K ;

KLIGER, A ;

SIEGEL, N ;

SMITH, D ;

FLYE, W .

TRANSPLANTATION, 1985, 40 (06) :610-614

[6] Reduction of acute renal allograft rejection by daclizumab [J].

Nashan, B ;

Light, S ;

Hardie, IR ;

Lin, A ;

Johnson, JR .

TRANSPLANTATION, 1999, 67 (01) :110-115

[7]

PIRSH JD, 1997, TRANSPLANTATION, V61, P1576

[8] MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL-ALLOGRAFT RECIPIENTS [J].

SOLLINGER, HW .

TRANSPLANTATION, 1995, 60 (03) :225-232

[9]

TESI RJ, 1993, CLIN TRANSPLANT, V7, P345

[10] A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation [J].

Vincenti, F ;

Lantz, M ;

Birnbaum, J ;

Garovoy, M ;

Mould, D ;

Hakimi, J ;

Nieforth, K ;

Light, S .

TRANSPLANTATION, 1997, 63 (01) :33-38

← 1 2 →